EU red tape hampers CRUK’s clinical trials

Originally published in icon Issue 1 2007

Apparently European bureaucracy has made running clinical trials a lot more difficult and more expensive.  Having one law which told each country the ground rules has backfired.  Each member is now apparently more likely to interpret the rules differently, making uniformity across countries even more uncertain.  (Ed: We’re not too sure we understand the logic of this CRUK press release!  But if clinical trials are now complicated and more expensive, how on earth are small natural vitamin companies supposed to mount a clinical trial??).

CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.